Since 2015, I have called for the full restoration of scientific integrity—for biomedical research to be ripped from the hands of politicized, captured institutions and returned to a rational, objective, methodologically rigorous foundation. I have written books, launched independent research platforms, published peer-reviewed critiques, and warned every agency head willing to listen: you cannot build sound public policy on corrupted science.

At long last, that restoration has begun.

In a historic pivot, the National Institutes of Health (NIH) has released a unified strategic directive that realigns its funding mechanisms with what I and others in the reform movement have demanded for a decade. The document makes clear that going forward, only research aligned with the Make America Healthy Again (MAHA) Commission’s mandate and the President’s Executive Order on Gold-Standard Science will receive support.

This is not a rhetorical adjustment. It is a wholesale redefinition of what the federal government will count as science.

The Strategic Shift: NIH Reoriented by Law and Mandate

The NIH’s new strategy abandons its siloed, fractured structure in favor of a unified, transparent, and accountable system that adheres to its statutory responsibilities under 42 U.S.C. § 282(b)(1)&(2). The transformation—authored and driven by Dr. Jay Bhattacharya—answers the public’s demand for merit-based funding, reproducibility, and meaningful health outcomes. Every NIH Institute and Center will now operate under a shared set of principles:

• Scientific merit

• National strategic alignment

• Programmatic balance

• Workforce development

• Return on public investment

It is a redirection from narrative-driven credentialism to actionable science that serves the American people.

MAHA Pillars Meet NIH Strategy

The NIH strategy now matches what we at IPAK have long identified as pillars of gold-standard science. This includes:

• Scientific-Mission Balance: A dual emphasis on discovery and public health relevance, prioritizing chronic childhood disease and nutrition.

• Agency-Wide Coordination: All funding decisions must now adhere to unified criteria—no more rogue IC agendas.

• Oversight of Foreign Research: All foreign projects will be tracked via independent, linked awards, with justification and risk assessment required.

• Transparent, Outcome-Oriented Disparities Research: Only studies with measurable, testable constructs will be supported.

• Civil-Rights-Compliant Training Programs: No more identity-based discrimination. Training must be merit-driven and safe for open inquiry.

Priority Domains: What This Means Practically

Training:

• Then: Fellowship selection based on identity or ideological alignment

• Now: Merit-based training free from discrimination, compliant with civil rights law

Replication:

• Then: Novelty-driven incentives, neglect of replication and negative findings

• Now: Funded replication, meta-replication, and publication of negative results

Real-World Data (RWD):

• Then: Fragmented, inaccessible clinical data; underutilized EHRs

• Now: Secure, integrated national RWD platform for scalable, privacy-protected research

Artificial Intelligence:

• Then: Proprietary black-box ML models with no transparency

• Now: Validated, explainable models governed by NIH replication standards

Nutrition:

• Then: Cross-sectional dietary recall with weak endpoints like BMI

• Now: Longitudinal nutrition studies tracking maternal diet, inflammation, insulin resistance, and microbiome profiles

Autism:

• Then: Genetic determinism with no environmental stratification or therapeutic insight

• Now: Etiology-focused data integration across omics and exposome; intervention-ready models

Alternative Testing Models (NAMs):

• Then: Default reliance on poorly translational animal models

• Now: NAM-first approach via ORIVA; justification required for any animal model funding

Valid Outcomes:

• Then: Use of vague sociopolitical abstractions as explanatory variables

• Now: Mandate for measurable, replicable, scientifically justified health outcome variables

Disparities Research:

• Then: Endless documentation of disparities without tested interventions

• Now: Solution-driven research with scalable intervention deployment

Foreign Research:

• Then: U.S. PIs outsourcing critical research without transparency or accountability

• Now: Linked, independently auditable awards with justification and oversight

Gender Dysphoria in Youth:

• Then: Promotion of puberty blockers, cross-sex hormones, and irreversible surgeries

• Now: Research focus on harm documentation, trauma recovery, long-term health

HIV Implementation Science:

• Then: Incremental innovations with weak translation

• Now: Priority on uptake, adherence, and outcome optimization for existing prevention and treatment tools

What Will No Longer Be Funded (or Will Be Heavily Scrutinized)

To be clear, many studies that would have easily cleared peer review just two years ago will no longer survive under the new gold-standard framework. Examples include:

• An R01 proposing repeated high-dose exposures to neurotoxins in rodents as a proxy for low-dose, chronic human exposure without NAM consideration.

• A single-site open-label trial of puberty suppression in adolescents with gender dysphoria, without long-term follow-up or control group.

• A nutrition study relying on participant recall and food frequency questionnaires to determine inflammatory status, without biological markers.

• Machine learning studies that use proprietary, non-interpretable algorithms to predict depression risk based on social media use without transparency, validation, or replicability.

• Disparities studies using “structural racism” as an independent variable without operationalization, measurement, or falsifiability.

• HIV grant applications emphasizing novel compounds with little emphasis on real-world adherence, access, or implementation barriers.

• Autism studies that exclude environmental toxicant data and omit stratification by immunological or mitochondrial biomarkers.

• Foreign lab collaborations proposing gain-of-function work with no U.S.-based replication or verification infrastructure.

These proposals are structurally misaligned with the NIH’s new strategic pillars. Investigators who continue to push them will find themselves unfundable.

Accountability and Public Trust

The NIH acknowledges it is a steward of finite public funds and that its scientific return-on-investment must be visible, measurable, and reproducible. It commits to transparent goal setting, strategic evaluation, and open, competitive peer review that adheres to law.

This is the closest the biomedical establishment has come in decades to admitting that its structure, incentives, and culture have failed. The new NIH vision is a full-throated endorsement of what IPAK, CHD, ICANN, MAHA, and the broader reform community have worked toward for years.

Final Word

The era of vague endpoints, unfalsifiable assumptions, and institutional gatekeeping is ending. If you are designing studies based on ideological conformity or editorial groupthink, you will be left behind.

But if you are ready to return to science as a discipline of discovery, grounded in method, truth-seeking, and human relevance, you are now exactly where NIH wants you to be.

The restoration has begun.

Share

Leave a comment

 

IPAK-EDU is grateful to Popular Rationalism as this piece was originally published there and is included in this news feed with mutual agreement. Read More